MTVA CIK: 1638287

MetaVia Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
16.6
FY22:
33.5
FY23:
22.5
FY24:
16.1
FY25:
10.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.22
FY22:
0.00
FY23:
0.27
FY24:
0.19
FY25:
0.25
Total assets
Change from FY21 to FY25
millions USD
FY21:
16.8
FY22:
33.5
FY23:
22.8
FY24:
16.3
FY25:
11.1

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
2.16
FY22:
11.8
FY23:
5.96
FY24:
8.27
FY25:
5.65
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.05
FY22:
0
FY23:
0.14
FY24:
0.06
FY25:
0.14
(positive)
Change from FY21 to FY25
millions USD
FY21:
14.6
FY22:
21.8
FY23:
16.7
FY24:
7.93
FY25:
5.33
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
16.8
FY22:
33.5
FY23:
22.8
FY24:
16.3
FY25:
11.1

All amounts in millions USD Data source:SEC EDGAR